ConductScience.org, home

Paper150690

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).

Ludwig J and 2 others. Virchows Arch A Pathol Anat Histol, 1978. Cited by 664 papers, by iCite.

Cite this record

ConductScience Library. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Papers, record 150690. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/150690

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis).
PubMed
Journal
Virchows Arch A Pathol Anat Histol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
664
iCite
Relative citation ratio, by iCite
18.5
iCite
Revised in PubMed
2019-11-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ludwig JJ
2Dickson ERE R
3McDonald GSG S

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver Cirrhosis, BiliaryMajor topic
Adult
Aged
Biopsy
Female
Humans
Liver
Male
Middle Aged
Syndrome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00244569Development of a Breath Test for Monitoring Patients With Liver DiseaseBackground

Source ClinicalTrials.gov

Download CSV of trials

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114266218PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.Am J Pathol1965https://conductscience.org/library/papers/14266218PubMed
25766764Studies on the pathogenesis of hepatolenticular degeneration. II. Cytochemical methods for the localization of copper.Arch Pathol1969https://conductscience.org/library/papers/5766764PubMed
313972306The problem of primary biliary cirrhosis.Am J Med1962https://conductscience.org/library/papers/13972306PubMed
46066569Primary biliary cirrhosis.Proc R Soc Med1967https://conductscience.org/library/papers/6066569PubMed
513982994Localization of the basic injury in primary biliary cirrhosis.JAMA1963https://conductscience.org/library/papers/13982994PubMed
6323135A review of lobular, portal, and periportal hepatitis. Interpretation of biopsy specimens without clinical data.Hum Pathol1977https://conductscience.org/library/papers/323135PubMed
74908705Nonsuppurative destructive chronic cholangitis and chronic hepatitis.Prog Liver Dis1970https://conductscience.org/library/papers/4908705PubMed

Download CSV of references

Cited by177

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 664 citations.

PMIDTitleJournalYearIn PapersSource
42871989Combined treatment of budesonide and ursodeoxycholic acid for non-cirrhotic primary biliary cholangitis: a systematic review and meta-analysis.Hepatobiliary Surg Nutr2026https://conductscience.org/library/papers/42871989PubMed
42842146Novel noninvasive technique for liver fibrosis evaluation using spatiotemporal analysis of strain elastography.J Med Ultrason (2001)2026https://conductscience.org/library/papers/42842146PubMed
42668455Bile Acid Profiles Define Disease-Specific Cholestatic States in Primary Sclerosing and Primary Biliary Cholangitis.Gastro Hep Adv2026https://conductscience.org/library/papers/42668455PubMed
42483735A Dual Time Window-driven Strategy to Optimize Primary Biliary Cholangitis Treatment via Alkaline Phosphatase Normalization.J Clin Transl Hepatol2026https://conductscience.org/library/papers/42483735PubMed
41956784[Impact of anti-gp210 and anti-centromere antibody dual positivity on clinical prognosis in patients with primary biliary cholangitis: risk analysis and establishment of response criteria].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/41956784PubMed
41883439Abnormalities of liver sinusoidal endothelial cells in primary biliary cholangitis.World J Exp Med2026https://conductscience.org/library/papers/41883439PubMed
41868880Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis.Ann Gastroenterol2026https://conductscience.org/library/papers/41868880PubMed
41846257Primary Biliary Cholangitis Increases Mortality Irrespective of Presence or Absence of Cirrhosis.Liver Int2026https://conductscience.org/library/papers/41846257PubMed
41751398Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma.Curr Issues Mol Biol2026https://conductscience.org/library/papers/41751398PubMed
41689244Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and Progression.J Gastroenterol Hepatol2026https://conductscience.org/library/papers/41689244PubMed
41680693Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort study.BMC Gastroenterol2026https://conductscience.org/library/papers/41680693PubMed
41669941Elevated Serum Soluble Tim-3 in Primary Biliary Cholangitis: Lack of Correlation with Cytokines, Chemokines, and Clinical Parameters.Turk J Gastroenterol2025https://conductscience.org/library/papers/41669941PubMed
41440960The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives.J Pers Med2025https://conductscience.org/library/papers/41440960PubMed
41257279Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis.World J Gastroenterol2025https://conductscience.org/library/papers/41257279PubMed
41023613Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis.BMC Gastroenterol2025https://conductscience.org/library/papers/41023613PubMed
40568038Primary biliary cholangitis: A historical perspective from xanthomatous lesions to modern molecular biology.World J Gastrointest Pathophysiol2025https://conductscience.org/library/papers/40568038PubMed
39732944Development and external validation of an early prediction model to identify irresponsive patients and prognosis of UDCA treatment in primary biliary cholangitis.Sci Rep2024https://conductscience.org/library/papers/39732944PubMed
39704223Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia.Am J Surg Pathol2025https://conductscience.org/library/papers/39704223PubMed
39588121Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?Open Life Sci2024https://conductscience.org/library/papers/39588121PubMed
39134906The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis.Hepatol Int2024https://conductscience.org/library/papers/39134906PubMed

See all 177 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/150690

GET https://conductscience.org/api/papers/v1/150690/cited_by?page=2